Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function

被引：16

作者：

Broxmeyer, Hal E. ^{[1
]}

机构：

[1] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA

来源：

HEMATOPOIETIC STEM CELLS VIII | 2012年 / 1266卷

基金：

美国国家卫生研究院;

关键词：

cord blood; stem and progenitor cells; intracellular signals; cytokines; HEMATOPOIETIC STEM-CELLS; UNRELATED BONE-MARROW; MULTIPOTENTIAL PROGENITOR CELLS; HIGH-EFFICIENCY RECOVERY; TAT-INTERACTING PROTEIN; EX-VIVO EXPANSION; CD26; INHIBITION; PLACENTAL-BLOOD; ACUTE-LEUKEMIA; REPLATING CAPACITY;

D O I：

10.1111/j.1749-6632.2012.06509.x

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Cord blood (CB) transplantation has been used over the last 24 years to treat patients with malignant and nonmalignant disorders. CB has its advantages and disadvantages compared with other sources of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) for transplantation. More knowledge of the cytokines and intracellular signaling molecules regulating HSCs and HPCs could be used to modulate these regulators for clinical benefit. This review provides information about the general field of CB transplantation and about studies from the author's laboratory that focus on regulation of HSCs and HPCs by CD26/DPPIV, SDF-1/CXCL12, the Rheb2-mTOR pathway, SIRT1, DEK, cyclin-dependent kinase inhibitors, and cytokines/growth factors. Cryopreservation of CB HSCs and HPCs is also briefly discussed.

引用

页码：151 / 160

页数：10

共 122 条

[111] Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival [J].

Wagner, JE ;

Barker, JN ;

DeFor, TE ;

Baker, KS ;

Blazar, BR ;

Eide, C ;

Goldman, A ;

Kersey, J ;

Krivit, W ;

MacMillan, ML ;

Orchard, PJ ;

Peters, C ;

Weisdorf, DJ ;

Ramsay, NKC ;

Davies, SM .

BLOOD, 2002, 100 (05) :1611-1618

[112]

WAGNER JE, 1992, BLOOD, V79, P1874

[113] ALLOGENEIC SIBLING UMBILICAL-CORD-BLOOD TRANSPLANTATION IN CHILDREN WITH MALIGNANT AND NONMALIGNANT DISEASE [J].

WAGNER, JE ;

KERNAN, NA ;

STEINBUCH, M ;

BROXMEYER, HE ;

GLUCKMAN, E .

LANCET, 1995, 346 (8969) :214-219

[114]

Wagner JE, 1996, BLOOD, V88, P795

[115] The DEK protein - an abundant and ubiquitous constituent of mammalian chromatin [J].

Waldmann, T ;

Scholten, I ;

Kappes, F ;

Hu, HG ;

Knippers, R .

GENE, 2004, 343 (01) :1-9

[116]

Welte K., 2011, CORD BLOOD BIOL T BA, P673

[117] Enhanced homing and engraftment of fresh but not ex vivo cultured murine marrow cells in submyeloablated hosts following CD26 inhibition by Diprotin A [J].

Wyss, Brandon K. ;

Donnelly, Abigail F. W. ;

Zhou, Dan ;

Sinn, Anthony L. ;

Pollok, Karen E. ;

Goebel, W. Scott .

EXPERIMENTAL HEMATOLOGY, 2009, 37 (07) :814-823

[118] Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow [J].

Xia, LJ ;

McDaniel, JM ;

Yago, T ;

Doeden, A ;

McEver, RP .

BLOOD, 2004, 104 (10) :3091-3096

[119] In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, P18INK4C [J].

Yuan, YZ ;

Shen, HM ;

Franklin, DS ;

Scadden, DT ;

Cheng, T .

NATURE CELL BIOLOGY, 2004, 6 (05) :436-442

[120] Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells [J].

Zhang, CC ;

Kaba, M ;

Ge, GT ;

Xie, K ;

Tong, W ;

Hug, C ;

Lodish, HF .

NATURE MEDICINE, 2006, 12 (02) :240-245

← 4 5 6 7 8 9 10 11 12 13 →